大動脈弁 大動脈弁狭窄症の超音波新規治療法：Lancet. 2023 Dec 16;402(10419):2317-2325.
Treatment of severe symptomatic aortic valve stenosis using non-invasive ultrasound therapy: a cohort study Emmanuel Mes...
大動脈弁
大動脈弁 弁膜症 低リスクTAVIの5年予後：N Engl J Med. 2023 Nov 23;389(21): 1949-1960.
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years Michael J Mack, et al. N Engl J Med. 2023 Nov ...
弁膜症 AVPの転機に影響を与える因子は？：J Thorac Cardiovasc Surg. 2021 Apr 16;S0022-5223(21)00612-7.
Late results of aortic valve repair for isolated severe aortic regurgitation Saadallah Tamer, et al. J Thorac Cardiovasc...
弁膜症 エネルギー損失/心拍出量はAVR後左室駆出率改善に相関する：Interactive Cardiovascular and Thoracic Surgery(2021)1-9
Blood flow energy loss: a predictor for the recovery of left ventricular function after bioprosthetic aortic valve repla...
弁膜症 AVRでウシ弁とブタ弁の違いは？：J Card Surg. 2022 Dec;37 (12):4555-4561.
Outcomes of bovine versus porcine surgical aortic valve replacement Sarah Yousef, et al. J Card Surg. 2022 Dec;37 (12):4...
弁膜症 心臓手術時のARへの介入なしは長期生存率に有意な影響を与えない：J Thorac Cardiovasc Surg. 2022 Dec;164 (6):1784-1792.1.
Fate of moderate aortic regurgitation after cardiac surgery Austin Ward, et al. J Thorac Cardiovasc Surg. 2022 Dec;164 (...
弁膜症 PARTNER3 Trial : TAVRのの有用性 for 低risk患者 / N Engl J Med 2019; 380:1695-1705
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients Michael J. Mack, M.D., et al...
弁膜症 PARTNER2 Trial : N Engl J Med 2016; 374:1609-1620
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients Martin B. Leon, M.D., et al., for the P...
弁膜症 PARTNER Trial : N Engl J Med 2010; 363:1597-1607
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery Martin B. Leon, M.D.,...